Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells-Reference-Cited by-同舟云学术

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Published:2013-05-05 Issue:6 Volume:19 Page:747-752
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Robbins Paul F,Lu Yong-Chen,El-Gamil Mona,Li Yong F,Gross Colin,Gartner Jared,Lin Jimmy C,Teer Jamie K,Cliften Paul,Tycksen Eric,Samuels Yardena,Rosenberg Steven A

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3161.pdf

Reference31 articles.

1. Dudley, M.E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850–854 (2002).

2. Dudley, M.E. et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J. Clin. Oncol. 26, 5233–5239 (2008).

3. Rosenberg, S.A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550–4557 (2011).

4. Nielsen, M. et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2, e796 (2007).

5. Marincola, F.M. et al. Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J. Immunother. Emphasis Tumor Immunol. 16, 13–23 (1994).

Cited by 954 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hidden element governing immunogenicity in tumoral neoepitopes;Medical Hypotheses;2024-10

2. Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells;Scientific Reports;2024-09-13

3. Advancements and Challenges in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

4. Altered epitopes enhance macrophage‐mediated anti‐tumour immunity to low‐immunogenic tumour mutations;Immunology;2024-08-22

5. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective;Vaccines;2024-08-22